CNBC

Dr. Scott Gottlieb: FDA's rare disease framework is 'a very good start'

Dr. Scott Gottlieb: FDA's rare disease framework is 'a very good start' Former FDA Commissioner Dr. Scott Gottlieb joins "Squawk Box' to discuss the FDA's new framework for accelerating the ...
American Enterprise Institute

Discussing the FDA’s new rare disease framework: Gottlieb on CNBC’s ‘Squawk Box’

Senior Fellow Scott Gottlieb discusses the FDA’s new rare disease framework on CNBC’s ‘Squawk Box.’ ...
American Enterprise Institute

Discussing the rapid expansion of CAR-T therapies and efforts to streamline FDA approvals for next-gen treatments: Gottlieb on CNBC’s ‘Sqauwk Box’

Senior Fellow Scott Gottlieb discusses the rapid expansion of CAR-T therapies, the implications of the new Psychedelics Executive Order, and efforts to streamline FDA approvals for next-gen treatments ...

Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," May 10, 2026

The following is the transcript of the interview with former FDA Commissioner Scott Gottlieb, who is on boards the of Pfizer ...